This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://localhost/temp/predkladatel/
n14http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/resource/domain/vavai/subjekt/
n11http://linked.opendata.cz/ontology/domain/vavai/
n18http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F13%3A33145232%21RIV14-MSM-15110___/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n16http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n19http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n8http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15110%2F13%3A33145232%21RIV14-MSM-15110___
rdf:type
n11:Vysledek skos:Concept
dcterms:description
Although systemic chemotherapy significantly improves the overal survival of pancreatic cancer patients, the prognosis remains extremely poor. The development of a drug resistence, either de novo or induced resistence, significantly limits the effectiveness of chemotherapy. Although systemic chemotherapy significantly improves the overal survival of pancreatic cancer patients, the prognosis remains extremely poor. The development of a drug resistence, either de novo or induced resistence, significantly limits the effectiveness of chemotherapy.
dcterms:title
Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients? Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?
skos:prefLabel
Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients? Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?
skos:notation
RIV/61989592:15110/13:33145232!RIV14-MSM-15110___
n11:predkladatel
n15:orjk%3A15110
n3:aktivita
n4:I
n3:aktivity
I
n3:cisloPeriodika
4
n3:dodaniDat
n8:2014
n3:domaciTvurceVysledku
n14:9595007 n14:5290791
n3:druhVysledku
n10:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n18:predkladatel
n3:idSjednocenehoVysledku
78306
n3:idVysledku
RIV/61989592:15110/13:33145232
n3:jazykVysledku
n19:eng
n3:klicovaSlova
gemcitabine; hENT1; SLC29A1; membrane transport protein; Pancreatic cancer
n3:klicoveSlovo
n5:SLC29A1 n5:hENT1 n5:Pancreatic%20cancer n5:membrane%20transport%20protein n5:gemcitabine
n3:kodStatuVydavatele
CH - Švýcarská konfederace
n3:kontrolniKodProRIV
[57859FA4CF6C]
n3:nazevZdroje
Pancreatology
n3:obor
n12:FD
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n8:2013
n3:svazekPeriodika
13
n3:tvurceVysledku
Melichar, Bohuslav Mohelníková Duchoňová, Beatrice
s:issn
1424-3903
s:numberOfPages
6
n16:doi
10.1016/j.pan.2013.09.005
n17:organizacniJednotka
15110